NCT06150846

Brief Summary

The purpose of this study is to obtain anonymous video clips of male semen at high magnification, to manually select out of the video spermatozoon images, and to manually classify their morphology by qualified embryologists based on the WHO Manual criteria in order to train the BAIBYS™ Fertility System. The study will enroll males attending the clinic who may elect to contribute their unused excess sample materials from semen analysis or IVF/ICSI (Intracytoplasmic sperm injection) which is a technique used during in vitro fertilization (IVF).

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Dec 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 21, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

November 29, 2023

Completed
2 days until next milestone

Study Start

First participant enrolled

December 1, 2023

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2024

Completed
Last Updated

July 23, 2024

Status Verified

July 1, 2024

Enrollment Period

8 months

First QC Date

November 21, 2023

Last Update Submit

July 21, 2024

Conditions

Keywords

SpermArtificial Inteligence

Outcome Measures

Primary Outcomes (1)

  • Obtaining 6,000 classified sperm images

    Obtaining 6,000 sperm images classified each by at least 2 embryologist based on the WHO 6th edition criteria to add to the AI training of the Baibys system.

    Each semen sample will be recorded for 10 minutes

Eligibility Criteria

Age22 Years+
Sexmale(Gender-based eligibility)
Gender Eligibility DetailsAssigned male at birth and possessing typical male anatomy (i.e., one or two testicles and penis)
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study will enroll 30-40 male subjects attending the clinic and willing to contribute their unused excess sample materials from semen analysis or IVF/ICSI. Enrollment will include three sub-populations of at least 15 patients to ensure diversity \[characteristics of ethnic and racial diversity, BMI diversity, and normal (\> WHO 5%ile cutoffs) versus abnormal morphology\].

You may qualify if:

  • Assigned male at birth and possessing typical male anatomy (i.e., one or two testicles and penis)
  • Scheduled to produce a semen sample for fertility evaluation
  • Able to produce a semen sample, including, in the judgement of the PI, ability to follow instructions provided in English by the physician or physician's team members
  • At least a 10th grade education level, to be able to read and understand the ICF; evaluated by either completion of 10th grade, or by any higher level of education or GED
  • Age 22 or older at the time of consent

You may not qualify if:

  • Known azoospermia prior to semen analysis.
  • Subjects with azoospermia or otherwise inadequate sample discovered during the trial will be compensated for their participation in recognition of their efforts to contribute to science, but will be replaced with an additional subject for the data collection and labeling to reach a total sample of up to 40 videos
  • History of chemotherapy or radiation within prior 12 months, due to increased chance of azoospermia
  • Developmental delays or other neurological impairment that could impair ability to freely consent, as evaluated by the PI
  • Any reason why in the sole judgement of the PI, consent to participate cannot be freely given

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CCRM Northern Virginia

Vienna, Virginia, 22182, United States

Location

Study Officials

  • Carter Owen, M.D.

    CCRM Fertility Clinic and IVF Clinic

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 21, 2023

First Posted

November 29, 2023

Study Start

December 1, 2023

Primary Completion

August 1, 2024

Study Completion

August 1, 2024

Last Updated

July 23, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will share

Anonymized patient's data including selection of sperm images/videos will be used together with the clinical study report and protocol will be shared to the medical writer and the supervisor author for the purpose of the the final publication.

Shared Documents
STUDY PROTOCOL, CSR
Time Frame
12 months after follow up pivotal trial is completed
Access Criteria
The IPD will be anonymized and shared as described in the plan. All those getting access will not be able to de-identify any patient's data. Anonymized patient's data including selection of sperm images/videos will be used together with the clinical study report and protocol will be shared to the medical writer and the supervisor author for the purpose of the the final publication.

Locations